is

JAMA Internal Medicine : Effect of Exercise Intervention on Functional Decline in Very Elderly Patients

Interview with Mikel Izquierdo, Ph.D, and Nicolás Martínez-Velilla, PhD, authors of Effect of Exercise Intervention on Functional Decline in Very Elderly Patients During Acute Hospitalization: A Randomized Clinical Trial, and William J. Hall, MD, author of A Novel Exercise Intervention and Functional Status in Very Elderly Patients During Acute Hospitalization












is

JAMA Cardiology : Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure

Interview with Andreas M. Zeiher, MD, author of Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure, and Peter Libby, MD, author of CHIPping Away at the Pathogenesis of Heart Failure





is

JAMA Internal Medicine : Analysis of Proposed Medicare Reforms on Prescription Drug Total Spending and Patient Cost-Sharing

Interview with Aaron Kesselheim, author of Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs, and Francis J. Crosson, M.D., author of Managing the Cost of Medicare Part B Drugs: Implications for the Program and Beneficiaries

















is

JAMA Cardiology : Rivaroxaban and Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm

Interview with Barry H. Greenberg, author of Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial, and Marvin A. Konstam, MD, author of Antithrombotic Therapy in Heart Failure—The Clot Thickens








is

JAMA Neurology : Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke

Interview with Adrian F. Hernandez, MD, MHS, author of Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study











is

JAMA Cardiology : Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels

Interview with Kausik K. Ray, MD, author of Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial, and Maarten JG. Leening, MD, PhD, author of Safety and Tolerability of Sustained Lipid-Lowering Therapy: Trial Data and Public Perception in a World Where Vaccines and Statins Are About to Collide




is

JAMA Cardiology : Longitudinal Associations Between Income Changes and Incident Cardiovascular Disease

Interview with Scott David Solomon, MD, and Stephen Yishu Wang, BS, authors of Longitudinal Associations Between Income Changes and Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities Study, and Edward P. Havranek, MD, author of The Influence of Social and Economic Factors on Heart Disease